DoD Peer Reviewed Alzheimer’s, Leveraging Approaches for Innovation in Care and Support Award


Funding Opportunity ID:327196
Opportunity Number:W81XWH-20-PRARP-LEAPINCASA
Opportunity Title:DoD Peer Reviewed Alzheimer’s, Leveraging Approaches for Innovation in Care and Support Award
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Category of Funding Activity:Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s):12.420
Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code:DOD-AMRAA
Agency Name:Department of Defense
Dept. of the Army — USAMRAA
Posted Date:May 19, 2020
Close Date:Jul 21, 2020
Last Updated Date:May 19, 2020
Award Ceiling:$0
Award Floor:$0
Estimated Total Program Funding:$15,000,000
Expected Number of Awards:1
Description:The intent of the FY20 PRARP LEAP-InCASA is to support innovative and impactful research that improves the quality of life and care for individuals, families and care providers living with the common symptoms of TBI and/or AD/ADRD as related to the PRARP’s mission (see Section II.A, Program Description). The proposed work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the contexts of the PRARP’s mission and vision. This can include innovations and research for symptom reduction (e.g., cognitive, behavioral, function, mood), resiliency factors, increasing or maintaining independence, and support for families and care providers. The FY20 PRARP LEAP-InCASA supports multi-institutional, harmonized research initiatives. As such, applications to the FY20 PRARP LEAP-InCASA require a Coordinating Center and a minimum of two Partnering Sites, representing three separate institutions within the application package. While the Coordinating Center provides overall infrastructure and support, each Partnering Site should develop its own unique research initiative that will be part of the overall project. While each Partnering Site will develop its own unique research initiative, the overall project must focus on a single symptomatology category as described later in this section. The application should also demonstrate the study team’s experience in both TBI and/or AD/ADRD research, as appropriate. Given the patient-centered intent of the FY20 PRARP LEAP-InCASA, animal research is prohibited.

Visit the Official Webpage For More Details on DoD Peer Reviewed Alzheimer’s, Leveraging Approaches for Innovation in Care and Support Award


Please enter your comment!
Please enter your name here